A Study of Injection HB0025 in Patients With Advanced Solid Tumors

NCT04678908 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor, Subjects

Interventions

DRUG: HB0025

Sponsor

Huabo Biopharm Co., Ltd.